Position: Postdoctoral researcher

Institute of Microbiology, Laboratory of Metabolomics, Plovdiv, Bulgaria

His early work focused on the biosynthesis of high-valuable secondary metabolites using plant in vitro systems as a production platform. Dr. Marchev has developed extensive expertise in plant biotechnology. The main area of Dr. Marchev’s research comprises the application of plant biotechnology tools and bioprocess engineering technologies in modulation of secondary metabolism in plant cells and tissue cultures at laboratory scale, as well as, metabolite profiling by NMR spectroscopy. Dr. Marchev is also interested in studying the antineoplastic potential of plant extracts and pure molecules in cancer cell lines.


Marchev A., Yordanova Z., Georgiev M. (2020) Green cell factories for advanced production of plant secondary metabolites. Submitted in Critical Reviews in Biotechnology.

Amirova K., Dimitrova P., Marchev A., Aneva Y., Georgiev M. (2019) Clinopodium vulgare L. (wild basil) extract and its active constituents modulate cyclooxygenase-2 expression in neutrophils. Food and Chemical Toxicology, 124:1-9. https:// doi: 10.1016/j.fct.2018.11.054.

Marchev A., Dimitrova P., Burns A., Kostov R., Dinkova-Kostova A., Georgiev M. (2017) Oxidative stress and chronic inflammation in osteoarthritis: can NRF2 counteract these partners in crime? Annals of the New York Academy of Sciences, 1401(1):114-135. https:// doi: 10.1111/nyas.13407.

EU PlantaSYST has received funding from the European Union's Horizon 2020 research and innovation programme, project PlantaSYST (SGA-CSA No. 739582 under FPA No. 664620), and the BG05M2OP001-1.003-001-C01 project, financed by the European Regional Development Fund through the "Science and Education for Smart Growth" Operational Programme SESG
  Calls: H2020-WIDESPREAD-2014-2015, Topic: WIDESPREAD-1-2014: Teaming, and H2020-WIDESPREAD-2016-2017, Topic: H2020-WIDESPREAD-01-2016-2017: TeamingPhase2